Skip to main content
News Hörauf 08.2019
Histological section of Onchocerca volvulus, the cause of river blindness, under the microscope: Sections of a living female worm with offspring in the uteri. The symbiotic bacteria are stained in red
© Institute of Medical Microbiology, Immunology and Parasitology (IMMIP) / University Hospital Bonn

Honors & Funding

Bill and Melinda Gates Funding for Prof. Hörauf

More than 21 million people in Africa are infected with the nematode Onchocerca volvulus, the cause of river blindness. Around one in ten of those affected goes blind. Parasitologists around Prof. Hörauf at the University Hospital Bonn are looking for new, more effective weapons against the insidious parasite. The evaluation of the success of treatment is important. They now want to develop a method in which artificial intelligence (AI) automatically evaluates tissue samples from patients under the microscope. The aim is to reduce the time required and to establish an objective standard for analysis. The project is supported by the Bill & Melinda Gates Foundation.


Contact

Prof. Dr. med. Achim Hörauf

Medical Microbiology, Immunology and Parasitology

Medical Faculty

University of Bonn

University Hospital of Bonn

achim.hoerauf@ukb.uni-bonn.de

Related news

News Marvin Supercomputer

Honors & Funding

Two years of the Marvin Supercomputer: Researchers in Bonn present their projects

—Two years after it went into operation, the University of Bonn celebrated the Marvin Supercomputer with a community event at the Research and Technology Center for Detector Physics (FTD). Researchers from various disciplines presented projects that had been carried out using high-performance computing and used the event as an opportunity for interdisciplinary exchange. A team lead by ImmunoSensation³ members Prof. Dr. Michael Hölzel (Institute of Experimental Oncology) and PD Dr. Gregor Hagelueken (Institute of Structural Biology) use Marvin to design new proteins.
View entry
Gut

Honors & Funding

Millions in funding for the new MikrobiomProCheck research project

—The human gut microbiome is as unique as a fingerprint. It plays a central role in chronic inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis. Yet its potential for diagnostics and personalized therapy for patients remains untapped. The MikrobiomProCheck research project aims to change this. To this end, the Leibniz Institute for Analytical Sciences (ISAS), the Universities of Bonn, Bielefeld, and Duisburg-Essen, Biofidus AG, and Lead Discovery Center GmbH are receiving approximately 3.4 million euros from the state government of NRW and the European Union.
View entry
Zwei Personen: Links Prof. Pröpstl und rechts Prof. Boztug

Honors & Funding

University of Bonn and University Hospital Bonn strengthen early-career clinical scientists

—The Faculty of Medicine at the University of Bonn and the University Hospital Bonn (UKB) are jointly launching the EKFS doctoral program IMMUNE PILOT, which introduces medical students to clinical-scientific research at an early stage. The structured program is positioned at the interface of immunology, neuroscience, and genetics and is aimed at students with a strong interest in research who aspire to pursue a career as clinician scientists. The program is funded by the Else Kröner-Fresenius Foundation (EKFS).
View entry

Back to the news overview